Biotech innovation is regularly faced with a thicket of prior art that applicants must navigate during patent prosecution. Examiners at...

SUMMARY: Biologic candidates evolve during clinical trials - so should your patents. Updated filings before public trial disclosures...

Too many biotech companies treat IP like a checkbox. Smart ones prune ruthlessly—and build value, not just volume: Prune entire families...

INTRODUCTION Executives usually ask these quantitative but high-level questions: How much money did we spend on patent work this year?...

As a biotech company, much of your value is in (pre-revenue) and/or protected by (post-revenue) your intellectual property. As you...

INTRODUCTORY COMMENTS RE: BIOTECH/PHARMA EXTENDED PATENT FAMILIES In complex art areas like biotech/biopharma, patent strategy is about...

It's that time of year again... Annual patent planning for your company/client(s) for next year. Here are some key dates to track as you...